Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis

Eur Respir J. 2010 Jul;36(1):206-8. doi: 10.1183/09031936.00159409.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • British Columbia
  • Ethambutol / adverse effects
  • Ethambutol / therapeutic use
  • Female
  • Humans
  • Isoniazid / adverse effects
  • Isoniazid / therapeutic use
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Pyrazinamide / adverse effects
  • Pyrazinamide / therapeutic use
  • Quality of Life*
  • Retrospective Studies
  • Rifampin / adverse effects
  • Rifampin / therapeutic use
  • Sickness Impact Profile
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Ethambutol
  • Isoniazid
  • Rifampin